EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanotechnology-Based Delivery of CRISPR/Cas9 for Cancer Treatment: A Comprehensive Review

Mohd Ahmar Rauf iD, Afifa Rao, Siva Sankari Sivasoorian, Arun K Iyer iD

Cells · 23.07.2025 · 14 (15) · 1136

DOI: 10.3390/cells14151136 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 23.07.2025. Verfasst von Mohd Ahmar Rauf und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Heme/Oncology Unit, University of Michigan, Ann Arbor, MI 48109, USA. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Neoplasms, Nanotechnology, Gene Transfer Techniques. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iyer lab, United States Department of Defense (DoD)/CDMRP.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats-associated protein 9)-mediated genome editing has emerged as a transformative tool in medicine, offering significant potential for cancer therapy because of its capacity to precisely target and alter the genetic modifications associated with the disease. However, a major challenge for its clinical translation is the safe and efficient in vivo delivery of CRISPR/Cas9 components to target cells. Nanotechnology is a promising solution to this problem. Nanocarriers, owing to their tunable physicochemical properties, can encapsulate and protect CRISPR/Cas9 components, enabling targeted delivery and enhanced cellular uptake. This review provides a comprehensive examination of the synergistic potential of CRISPR/Cas9 and nanotechnology in cancer therapy and explores their integrated therapeutic applications in gene editing and immunotherapy. A critical aspect of in vivo CRISPR/Cas9 application is to achieve effective localization at the tumor site while minimizing off-target effects. Nanocarriers can be engineered to overcome biological barriers, thereby augmenting tumor-specific delivery and facilitating intracellular uptake. Furthermore, their design allows for controlled release of the therapeutic payload, ensuring sustained efficacy and reduced systemic toxicity. The optimization of nanocarrier attributes, including size, shape, surface charge, and composition, is crucial for improving the cellular internalization, endosomal escape, and nuclear localization of CRISPR/Cas9. Moreover, surface functionalization with targeting ligands can enhance the specificity of cancer cells, leading to improved gene-editing accuracy. This review thoroughly discusses the challenges associated with in vivo CRISPR/Cas9 delivery and the innovative nanotechnological strategies employed to overcome them, highlighting their combined potential for advancing cancer treatment for clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsNeoplasmsNanotechnologyGene Transfer TechniquesHumansGene EditingAnimalsGenetic Therapy

Stichwörter der Autor:innen

CRISPR/Cas9gene editingnanotechnology

Autor:innen und Institutionen

  • Department of Internal Medicine, Heme/Oncology Unit, University of Michigan, Ann Arbor, MI 48109, USA.
  • Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA.
  • Jamia Hamdard Medical College, Jamia Hamdard University, New Delhi 110062, India.

ORCID-Profile: Mohd Ahmar Rauf, Arun K Iyer

Förderung

  • Iyer lab
  • United States Department of Defense (DoD)/CDMRP

Zitieren

APA

Rauf, M. A., Rao, A., Sivasoorian, S. S., & Iyer, A. K. (2025). Nanotechnology-Based Delivery of CRISPR/Cas9 for Cancer Treatment: A Comprehensive Review. Cells, 14(15), 1136. https://doi.org/10.3390/cells14151136

Vancouver

Rauf MA, Rao A, Sivasoorian SS, Iyer AK. Nanotechnology-Based Delivery of CRISPR/Cas9 for Cancer Treatment: A Comprehensive Review. Cells. 2025;14(15):1136. doi:10.3390/cells14151136

BibTeX
@article{Rauf2025,
  author = {Rauf, Mohd Ahmar and Rao, Afifa and Sivasoorian, Siva Sankari and Iyer, Arun K},
  title = {Nanotechnology-Based Delivery of CRISPR/Cas9 for Cancer Treatment: A Comprehensive Review},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {15},
  pages = {1136},
  doi = {10.3390/cells14151136}
}
Kostenlos starten →